Boehringer Ingelheim Korea
Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains an independent, family-owned company. Globally, we have some 50,000 employees who help create value through innovation for our three business areas: human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.
Our regional head office for South East Asia and South Korea, “SEASK” is in Singapore working with the 7 key countries: Singapore, Malaysia, Indonesia, Vietnam, Philippines, Thailand and South Korea.
In South Korea, we are a workforce of 248 talented and diverse individuals. We are currently one of the top leading pharmaceutical companies both in the human pharma and the animal health business in the market.